This inventor holds 1 USPTO granted patent. Top assignee: Yeda Research and Develpment & Co. Ltd. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Christopher J Arnush: Innovator in Anti-Inflammatory Peptides
Introduction
Christopher J Arnush is a notable inventor based in Rehovot, Israel. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-inflammatory peptides. His innovative work has the potential to impact the treatment of various inflammatory conditions and allergic reactions.
Latest Patents
Arnush holds a patent for "Anti-inflammatory peptides and use thereof." This patent includes isolated peptides of 13-30 amino acids that comprise 5-9 consecutive repeats of the amino acid pair Alanine-Leucine or Alanine-Valine. The peptides also feature a stretch of 1-3 Lysine residues present at one of the peptide's termini. Notably, the only Lysine residue in the isolated peptide is part of this stretch. The patent further details pharmaceutical compositions that utilize these peptides, methods for treating inflammatory conditions, and techniques for neutralizing the activity of lipopolysaccharides.
Career Highlights
Arnush is associated with Yeda Research and Development Co. Ltd., where he continues to advance his research and innovations. His work is characterized by a commitment to developing effective therapeutic solutions.
Collaborations
Arnush has collaborated with notable colleagues, including Yechiel Shai and Avner Fink, contributing to a dynamic research environment that fosters innovation.
Conclusion
Christopher J Arnush is a prominent figure in the field of anti-inflammatory research, with a patent that showcases his innovative approach to addressing significant health challenges. His contributions are paving the way for new therapeutic options in the pharmaceutical industry.